<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02267681</url>
  </required_header>
  <id_info>
    <org_study_id>Ufuk University</org_study_id>
    <nct_id>NCT02267681</nct_id>
  </id_info>
  <brief_title>Opioid Effects on Cognitive Function Following Colonoscopy</brief_title>
  <official_title>The Effects of Fentanyl and Alfentanil as an Adjunct to Propofol on Cognitive Functions for Sedation in Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Perihan Ekmekçi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ufuk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the effects of fentanyl and alfentanil on postprocedural cognitive
      function in elective endoscopy.

      150 patients will be enrolled in the study. Patients meeting eligibility criteria will be
      randomly allocated to three groups.

      The patients in Group A will be given propofol and alfentanil. The patients in Group F will
      be given propofol and fentanyl. Group P is designated as the control group and the patients
      will be given propofol for sedation.

      Awareness, vital signs and pain will be evaluated. Side effects will be recorded. Patient and
      endoscopist satisfaction will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we aimed to compare the effects of sedation provided by propofol with the
      addition of the short-acting opioid alfentanil and long-acting opioid fentanyl on cognitive
      functions, pain, side effects during the procedure and the endoscopist and patient
      satisfaction.

      Following the approval of Kırıkkale University ethics committee, 150 patients ages between 18
      and 65 ASA I-III scheduled for elective endoscopy and colonoscopy will be enrolled in the
      study.

      After obtaining written informed consent, APAIS (The Amsterdam Preoperative Anxiety and
      Information Scale) and MMTS (Mini Mental Test Scoring) tests will given to patients.
      Following TDT (Trieger Dot Test) and DSST (Digit Symbol Substitution Test), the patients will
      be randomly allocated to either Propofol-Alfentanil (Group A), Propofol-Fentanyl (Group F) or
      Propofol-Control (Group P) which consists of 50 patients each.

      The patients in Group A will be given 100 mcg/kg/min propofol infusion and 10 mcg/kg loading
      dose of alfentanil and 5 mcg/kg additional bolus of alfentanil whenever FPS (Faces Pain
      Scale) is greater than 3 or the patients can not tolerate the procedure.

      The patients in Group F will be given 100 mcg/kg/min propofol infusion and 1 mcg/kg loading
      dose of fentanyl and 5 mcg/kg additional bolus of fentanyl whenever FPS (Faces Pain Scale) is
      greater than 3 or the patients could not tolerate the procedure.

      Group P is designated as the control group and the patients will be given 100mcg/kg/min
      infusion and sedation will be achieved via 1 mg/kg propofol loading dose and 0.5 mg/kg
      propofol additional bolus will be given whenever the patients can not tolerate the procedure
      or FPS is greater than 3.

      BIS values, mean arterial pressures, heart rates, peripheral oxygen saturations will be
      recorded in all three groups. FPS and VAS (Visual Analogue Scale) values will be evaluated.

      Patients with intraprocedural desaturation, hypo- or hypertension, brady- or tachycardia,
      nausea, vomiting and apnea will be recorded. Total amounts of drugs administered will be
      recorded.

      Infusions will be ceased at the end of the procedure and the time for OAAS/S to exceed 3 will
      be recorded and TDT and DSST will be repeated at 5, 15 and 30th minutes. Patient and
      endoscopist satisfaction will be evaluated in all cases.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cognitive dysfunction</measure>
    <time_frame>during the 30 minutes after the termination of the procedure</time_frame>
    <description>as evaluated using Trieger dot test,Mini mental test and Digit symbol substitution test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient and endoscopist satisfaction</measure>
    <time_frame>following the procedure</time_frame>
    <description>as evaluated using a 5-point Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>during the 30 minutes after the termination of the procedure</time_frame>
    <description>as evaluated using VAS score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>during the 30 minutes after the termination of the procedure</time_frame>
    <description>hypotension, hypertension, bradycardia, tachycardia, apnea, nausea and vomiting</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Digestive System Diseases</condition>
  <condition>Disorientation</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in Group A will be given 100 mcg/kg/min propofol infusion and 10 mcg/kg loading dose of alfentanil and 5 mcg/kg additional bolus of alfentanil whenever FPS (Faces Pain Scale) is greater than 3 or the patients can not tolerate the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group F</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in Group F will be given 100 mcg/kg/min propofol infusion and 1 mcg/kg loading dose of fentanyl and 5 mcg/kg additional bolus of fentanyl whenever FPS (Faces Pain Scale) is greater than 3 or the patients can not tolerate the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group P</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group P is designated as the control group and the patients will be given 100mcg/kg/min infusion and sedation will be achieved via 1 mg/kg propofol loading dose and 0.5 mg/kg propofol additional bolus will be given whenever the patients can not tolerate the procedure or FPS is greater than 3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Intravenous fentanyl for sedation/analgesia</description>
    <arm_group_label>Group F</arm_group_label>
    <other_name>Talinat</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alfentanil</intervention_name>
    <description>Intravenous alfentanyl for sedation/analgesia</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>Rapifen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Intravenous propofol for sedation</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group F</arm_group_label>
    <arm_group_label>Group P</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages between 18-65

          -  American Society of Anesthesiologists classification I-III

          -  Patients scheduled to undergo elective colonoscopy or endoscopy and colonoscopy

        Exclusion Criteria:

          -  Patients younger than 18 or older than 65

          -  Mini mental test score &lt; 26

          -  APAIS (The Amsterdam Preoperative Anxiety and Information Scale) &gt;10

          -  Serious systemic disease

          -  Neuropsychiatric disorder

          -  Chronic alcohol abuse

          -  Morbid obesity

          -  History of anesthesia in the last 7 days

          -  Known allergy to study drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Perihan Ekmekçi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UFUK UNIVERSITY FACULTY OF MEDICINE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ufuk University Dr Rıdvan Ege Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06520</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Froehlich F, Gonvers JJ, Fried M. Conscious sedation, clinically relevant complications and monitoring of endoscopy: results of a nationwide survey in Switzerland. Endoscopy. 1994 Feb;26(2):231-4.</citation>
    <PMID>8026371</PMID>
  </reference>
  <reference>
    <citation>Türk HŞ, Aydoğmuş M, Unsal O, Köksal HM, Açik ME, Oba S. Sedation-analgesia in elective colonoscopy: propofol-fentanyl versus propofol-alfentanil. Braz J Anesthesiol. 2013 Jul-Aug;63(4):352-7. doi: 10.1016/j.bjane.2012.07.007. Epub 2013 Aug 13.</citation>
    <PMID>24565243</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2014</study_first_submitted>
  <study_first_submitted_qc>October 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2014</study_first_posted>
  <last_update_submitted>June 28, 2016</last_update_submitted>
  <last_update_submitted_qc>June 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ufuk University</investigator_affiliation>
    <investigator_full_name>Perihan Ekmekçi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Digestive System Diseases</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Confusion</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Alfentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

